Mylan Faces Federal Antitrust Investigator In EpiPen Business

Federal antitrust regulators are eyeing big drugmaker Mylan's EpiPen business, the company said Monday.

Mylan, in a statement, said the Federal Trade Commission asked it "months ago" for information about its anti-allergy EpiPen "as part of a preliminary investigation."

The disclosure comes nearly five months after two United States senators asked the FTC to investigate whether Mylan violated antitrust laws to protect the auto-injector EpiPen from competition.

Back to news